K Douglas, S J Bowman. Show Affiliations »
Abstract
Entities: Gene Species
Mesh： See more » Antibodies, Monoclonal/therapeutic useAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/epidemiologyArthritis, Rheumatoid/therapyEligibility Determination/statistics & numerical dataEtanerceptHumansImmunoglobulin G/therapeutic useIncidenceInfliximabPrevalenceReceptors, Tumor Necrosis Factor/therapeutic useTumor Necrosis Factor-alpha/antagonists & inhibitorsUnited Kingdom/epidemiology
Substances： See more » Antibodies, MonoclonalAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaInfliximabEtanercept
Year: 2001 PMID： 11752515 DOI： 10.1093/rheumatology/40.12.1416
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580